Specialty Care Advisor (Field based in Kochi) at Bristol-Myers Squibb

India

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Healthcare, OncologyIndustries

Requirements

  • Pharmacy/Science Graduate
  • 5-8 years of Oncology sales experience
  • Consistent Sales Track Record
  • Languages: English, Hindi & Malayalam
  • Work experience of 5 or more years in Oncology
  • Experience working with thought leaders in Oncology
  • Good understanding of working in Corporate Hospitals, Government accounts
  • Field-based in Kochi

Responsibilities

  • Identify accurately the sales potential of all customers
  • Sell/Promote awareness of the Oncology product range to achieve planned sales objectives
  • Continually monitor and analyze new business opportunities within the defined territory
  • Develop and maintain effective new and existing business relationships through regular contact and liaison, including local medical organizations and key university and hospital departments
  • Identify, in conjunction with Manager, appropriate trade displays/exhibits to attend or conduct
  • Assist in/organize meetings and seminars to promote company image and/or product awareness to achieve sales objectives
  • Ensure effective management of territory by efficient time management, record keeping, resource utilization that meet company requirements
  • Actively participate in all meetings and development activities to ensure sales skills, product and industry knowledge is maintained
  • Maintain all SFE parameters as per BMS guidelines
  • Managing the process of hospital formulary inclusion to allow usage of product within that hospital
  • Planning and executing scientific meetings with Oncologists & Hematologists to increase awareness of Immuno-Oncology & Hematology drugs
  • Report safety information, including adverse events, in accordance with BMS Standard Operating Procedures
  • Achieve sales targets in defined territory (Cochin and adjoining territories) through scientific interactions with Oncologists & Hematologists to establish usage of Immuno-Oncology and Hematology drugs in right patients

Skills

Oncology Sales
Hematology
Immuno-Oncology
Territory Management
Scientific Interaction
KOL Engagement
Sales Promotion
Business Development
Relationship Management
Seminars Organization

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI